Browsing by Author Toh, H.C.

Showing results 1 to 17 of 17
Issue DateTitleAuthor(s)
May-2012A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targetsDeng, N. ; Goh, L.K. ; Wang, H.; Das, K. ; Tao, J.; Tan, I.B.; Zhang, S.; Lee, M.; Wu, J.; Lim, K.H.; Lei, Z.; Goh, G.; Lim, Q.-Y.; Tan, A.L.-K.; Poh, D.Y.S.; Riahi, S.; Bell, S.; Shi, M.M.; Linnartz, R.; Zhu, F.; Yeoh, K.G.; Toh, H.C.; Yong, W.P. ; Cheong, H.C.; Rha, S.Y.; Boussioutas, A.; Grabsch, H.; Rozen, S. ; Tan, P. 
2008Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinomaHuynh, H.; Yu, K.; Wu, J.; Lee, M.H.; Hor, H.; Soo, K.C.; Toh, H.C.; Tan, P.; Salto-Tellez, M. ; Chow, P.K.H.; Lee, C.K.; Soong, R. ; Goh, B.C. ; Lee, H.S. ; Somani, A.; Tan, P.H. ; Palanisamy, N.; Kalpana, R.
Apr-2013Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variationsToh, S.T.; Jin, Y.; Liu, L.; Wang, J.; Babrzadeh, F.; Gharizadeh, B.; Ronaghi, M.; Toh, H.C.; Chow, P.K.-H. ; Chung, A.Y.-F; Ooi, L.L.P.-J.; Lee, C.G.-L.
1-May-2012Enhancing immunostimulatory function of human embryonic stem cell-derived dendritic cells by CD1d overexpressionZeng, J.; Shahbazi, M.; Wu, C.; Toh, H.C.; Wang, S. 
Jul-2009G-CSF induces a potentially tolerant gene and immunophenotype profile in T cells in vivoToh, H.C.; Sun, L.; Soe, Y.; Wu, Y.; Phoon, Y.P.; Chia, W.K.; Wu, J.; Wong, K.Y.; Tan, P. 
Jan-2013Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesisHo, I.A.W.; Toh, H.C.; Ng, W.H.; Teo, Y.L.; Guo, C.M.; Hui, K.M. ; Lam, P.Y.P.
Mar-2010Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patientsChew, V.; Tow, C.; Teo, M.; Wong, H.L.; Chan, J.; Gehring, A.; Loh, M. ; Bolze, A.; Quek, R.; Lee, V.K.M.; Lee, K.H.; Abastado, J.-P.; Toh, H.C.; Nardin, A.
Aug-2011Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapyTan, I.B.; Ivanova, T.; Lim, K.H.; Ong, C.W. ; Deng, N. ; Lee, J.; Tan, S.H.; Wu, J.; Lee, M.H.; Ooi, C.H. ; Rha, S.Y.; Wong, W.K.; Boussioutas, A.; Yeoh, K.G.; So, J.; Yong, W.P. ; Tsuburaya, A.; Grabsch, H.; Toh, H.C.; Rozen, S. ; Cheong, J.H.; Noh, S.H.; Wan, W.K.; Ajani, J.A.; Lee, J.; Tellez, M.S. ; Tan, P. 
Jul-2012MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanismsWang, Y.; Toh, H.C.; Chow, P. ; Chung, A.Y.F.; Meyers, D.J.; Cole, P.A.; Ooi, L.L.P.J.; Lee, C.G.L.
29-Jul-2013MicroRNA-224 Targets SMAD Family Member 4 to Promote Cell Proliferation and Negatively Influence Patient SurvivalWang, Y.; Ren, J.; Gao, Y.; Ma, J.Z.I.; Toh, H.C.; Chow, P. ; Chung, A.Y.F.; Ooi, L.L.P.J.; Lee, C.G.L.
15-Jan-2013Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinomaToh, H.C.; Chen, P.-J.; Carr, B.I.; Knox, J.J.; Gill, S.; Ansell, P.; McKeegan, E.M.; Dowell, B.; Pedersen, M.; Qin, Q.; Qian, J.; Scappaticci, F.A.; Ricker, J.L.; Carlson, D.M.; Yong, W.P. 
Nov-2011Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignanciesYong, W.P. ; Goh, B.C.; Soo, R.A. ; Toh, H.C.; Ethirajulu, K.; Wood, J.; Novotny-Diermayr, V.; Lee, S.C. ; Yeo, W.L. ; Chan, D.; Lim, D.; Seah, E.; Lim, R.; Zhu, J.
Jul-2012Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancerFarid, M.; Chowbay, B.; Chen, X.; Tan, S.H. ; Ramasamy, S.; Koo, W.H.; Toh, H.C.; Choo, S.P.; Ong, S.Y.K.
2010Risk communication in clinical trials: A cognitive experiment and a surveyCheung, Y.B. ; Wee, H.L. ; Thumboo, J.; Goh, C. ; Pietrobon, R. ; Toh, H.C.; Yong, Y.F. ; Tan, S.B. 
Jan-2014Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse modelBard-Chapeau, E.A.; Nguyen, A.-T.; Rust, A.G.; Sayadi, A.; Lee, P.; Chua, B.Q.; New, L.-S. ; De Jong, J.; Ward, J.M.; Chin, C.K.Y.; Chew, V.; Toh, H.C.; Abastado, J.-P.; Benoukraf, T. ; Soong, R.; Bard, F.A.; Dupuy, A.J.; Johnson, R.L.; Radda, G.K.; Chan, E.C.Y. ; Wessels, L.F.A.; Adams, D.J.; Jenkins, N.A.; Copeland, N.G.
Nov-2006Use of sirolimus for Epstein-Barr virus-positive smooth-muscle tumourToh, H.C.; Teo, M.; Ong, K.W.; Lee, V.; Chan, E.; Lee, A.S. ; Vathsala, A.
2013Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cellsPhang, R.-Z.; Tay, F.C.; Goh, S.-L.; Lau, C.-H.; Zhu, H.; Tan, W.-K.; Liang, Q.; Chen, C.; Du, S.; Li, Z. ; Tay, J.C.-K.; Wu, C.; Zeng, J.; Fan, W.; Toh, H.C.; Wang, S.